San Francisco, 24 January, Plasma Protein Therapeutic Market Size,
Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Factor
VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts,
2018 - 2025
The global plasma protein therapeutics market size is expected to reach USD 33.15
billion by 2025, according to a new report by Grand View Research, Inc. It is
projected to register a CAGR of 4.8% over the forecast period. The growth can
be attributed to high prevalence of bleeding and other rare disorders, rising
investment in R&D, and increasing use of plasma-derived products in
neurology and other therapeutic indications.
Plasma-derived proteins are
primarily used as replacement therapies to treat chronic, rare diseases.
Patients that rely on these medications require regular injections or infusions
throughout their lives. While there are more than 250 products derived from
plasma, key players generally rely on Immunoglobulin (IG), albumin, and factor
VIII to drive sales and profitability.
Over the past decade, the
plasma protein therapeutics market has grown lucratively with immunoglobulin
capturing the major market share. Demand for plasma derived-products is driven
by rising disease prevalence, geriatric population, and improved access to
drugs in emerging markets. Approvals of new plasma-derived therapies are
anticipated to further fuel the demand. Developing countries such as China and
Brazil offer new investment avenues to the global market giants.
Access Full Research
Report On , Plasma Protein Therapeutic
Market Analysis:
www.grandviewresearch.com/industry-analysis/plasma-protein-therapeutic
www.grandviewresearch.com/industry-analysis/plasma-protein-therapeutic
Further key findings from the report suggest:
·
Germany leads the European
market, supported by high demand for blood components, presence of key players,
large addressable population, and rising disease prevalence
·
Demand for immunoglobulin is
expected to continue rising owing to prevalence of primary immunodeficiencies,
usage in new indications, and ease of administration
·
Non-plasma based recombinant
therapies are likely to compete with plasma-derived products in the factor VIII
market
·
Asia Pacific is expected to
exhibit high growth over the forecast period fueled by increasing healthcare
expenditure, presence of a large number patients. improved ratio of patients
suffering from disease and patients receiving treatment, low-cost production of
drugs, and improvement in diagnostic technology.
·
Major players operating in the
plasma protein therapeutics market include CSL Behring, Grifols, S.A., Shire
Plc, Octapharma AG, Biotest AG, and Kedrion S.P.A. Regional expansion, broad
product portfolio, and merger & acquisitions are chief strategic
undertakings adopted by key players.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the
global plasma protein therapeutics market on the basis of product, application,
and region:
Plasma Proteins Therapeutics
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Albumin
·
Immunoglobulin
·
Factor VIII
Plasma Proteins Therapeutics
Application Outlook (Revenue, USD Million, 2014 - 2025)
·
Hemophilia
·
Primary Immunodeficiency
Disorder (PID)
·
Idiopathic Thrombocytopenic
Purpura (ITP)
·
Others
Plasma Protein Therapeutics
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa (MEA)
o
South Africa
o
Saudi Arabia
Access Full Press Release of this Report: www.grandviewresearch.com/press-release/global-plasma-protein-therapeutics-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
No comments:
Post a Comment